Alamar Biosciences, Inc. (California) (ALMR)
29.31
-1.23
(-4.03%)
USD |
NASDAQ |
Sep 01, 16:00
29.36
+0.05
(+0.17%)
After-Hours: 18:59
Alamar Biosciences Total Long Term Debt (Quarterly) : 49.13M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.13M |
| March 31, 2026 | 338.95M |
| Date | Value |
|---|---|
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| 10X Genomics, Inc. | 66.78M |
| Personalis, Inc. | 31.06M |
| Twist Bioscience Corp. | 84.96M |
| Adaptive Biotechnologies Corp. | 401.68M |
| Champions Oncology, Inc. | 3.078M |